Five points to remember if FDA issues a Form 483

October 2, 2020 Becky Hurt

Our regulatory compliance consulting team includes over 80 former regulators and
inspectors who, alongside seasoned industry experts, help clients mitigate compliance
risks, manage remediations, and restore confidence.
Contact info@parexel.com or visit parexel.com/compliance to learn more.

 

Previous Article
Optimizing SOPS in the Digital World
Optimizing SOPS in the Digital World

For any company on the receiving end of an FDA 483 or warning letter, standard operating procedures (SOPs) ...

Next Article
The impact of COVID-19 on clinical trials in rare disease and oncology
The impact of COVID-19 on clinical trials in rare disease and oncology